Concepedia

Author

Robert Justice

Center for Drug Evaluation and Research

Also Known As

R Justice, R L Justice, R. Justice, R. L. Justice, Robert Justice, Robert L. Justice

94

Publications

14.2K

Citations

49

H-Index

68

Concepts

All Affiliations

Center for Drug Evaluation and ResearchUnited States Food and Drug AdministrationUnited States Department of Health and Human Services
RJ

About

Robert Justice is an author at Center for Drug Evaluation and Research specializing in oncology, medicine, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

22

25

2.9K

2

Health Sciences

11

11

1K

3

Cell Biology

1

1

11

4

Diagnostic Sciences

1

1

162

5

Emergency Medicine

1

1

71

Robert Justice

×

47

Publications

7K

Citations

40

H-Index

YearCitations

FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma

Bhupinder Mann, John R. Johnson, Martin H. Cohen,

The Oncologist

2007

1.3K

Approval Summary: Imatinib Mesylate in the Treatment of Metastatic and/or Unresectable Malignant Gastrointestinal Stromal Tumors

Martin H. Cohen, Ann T. Farrell, Robert Justice,

The Oncologist

2009

428

FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer

Laleh Amiri‐Kordestani, Gideon M. Blumenthal, Qiang Xu,

Clinical Cancer Research

2014

336

Bortezomib for the Treatment of Mantle Cell Lymphoma

Robert C. Kane, Ramzi Dagher, Ann T. Farrell,

Clinical Cancer Research

2007

330

FDA Drug Approval Summary: Lapatinib in Combination with Capecitabine for Previously Treated Metastatic Breast Cancer That Overexpresses HER-2

Qin Ryan, Amna Ibrahim, Martin H. Cohen,

The Oncologist

2008

303

FDA Approval Summary: Crizotinib for the Treatment of Metastatic Non-Small Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements

Dickran Kazandjian, Gideon M. Blumenthal, Huanyu Chen,

The Oncologist

2014

283

Vorinostat for Treatment of Cutaneous Manifestations of Advanced Primary Cutaneous T-Cell Lymphoma

Bhupinder Mann, John R. Johnson, Kun He,

Clinical Cancer Research

2007

260

Food and Drug Administration Drug Approval Summary: Sunitinib Malate for the Treatment of Gastrointestinal Stromal Tumor and Advanced Renal Cell Carcinoma

Edwin P. Rock, Vicki Goodman, Janet Jiang,

The Oncologist

2007

242

FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma

Virginia E. Kwitkowski, Tatiana M. Prowell, Amna Ibrahim,

The Oncologist

2010

240

Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate

Michael H. Brave, Vicki Goodman, Edvardas Kaminskas,

Clinical Cancer Research

2008

239

Page 1